formoterol fumarate has been researched along with darifenacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, KH; Dunham, SL; Hughes, AD; Jasper, JR; King, KE; Lee, TW; Mammen, M; Martin, J; Steinfeld, T | 1 |
| Alcaraz, L; Bailey, A; Cadogan, E; Christie, J; Connolly, S; Cook, AR; Fisher, AJ; Hill, S; Humphries, A; Ingall, AH; Kane, Z; Paine, S; Pairaudeau, G; Stocks, MJ; Young, A | 1 |
2 other study(ies) available for formoterol fumarate and darifenacin
| Article | Year |
|---|---|
Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.
Topics: Adrenergic beta-2 Receptor Agonists; Bronchodilator Agents; Drug Design; Humans; Molecular Structure; Muscarinic Antagonists; Receptors, Adrenergic, beta-2; Receptors, Muscarinic; Structure-Activity Relationship | 2011 |
Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonists.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Bronchodilator Agents; Drug Design; Drug Evaluation, Preclinical; Guinea Pigs; Receptors, Adrenergic, beta-2; Structure-Activity Relationship; Thiazoles | 2011 |